
Suhayl Samih Dhib-Jalbut MD
Neuroimmunology/Multiple Sclerosis
Professor and Chairman, Department of Neurology, Rutgers-RWJ Medical School and New Jersey Medical School
Join to view full profile
125 Paterson StSuite 6100New Brunswick, NJ 08901
Phone+1 732-235-7733
Fax+1 732-235-7041
Dr. Dhib-Jalbut is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Suhayl Dhib-Jalbut is a distinguished neurologist based in New Brunswick, NJ, specializing in neuroimmunology and multiple sclerosis. He completed his medical education at the American University of Beirut, his neurology residency at the University of Cincinnati and a Neuroimmunology/Multiple Sclerosis fellowship at the NIH. He held multiple positions including Senior Vice President at RWJBH, Professor with tenure and Chairman at Rutgers Robert Wood Johnson Medical School and New Jersey Medical School, and Chief at Robert Wood Johnson University Hospital. His previous roles include being an attending physician and consultant at both the University of Maryland Medical Center and the Baltimore Veterans Center. He had served as president of the Americas Committee for Treatment and Research in MS (ACTRIMS). He is currently a tenured professor and the Ruth Dunietz Kushner and Michael Jay Serwitz Chair in Multiple Sclerosis at Rutgers. His research is focused on multiple sclerosis funded by the NIH, NMSS, and industry. His work has been recognized through various awards, including the Medical Excellence Award from the National MS Society, the Edward J. Ill Excellence in Medicine Award, CMS Meaningful Use Certifications and Honorary Alumnus of Rutgers-RWJMS.
Education & Training
National Institutes of HealthSr. Staff Fellow, Neuroimmunology & Multiple Sclerosis, AOA, 1985 - 1990
University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 1981 - 1985
American University of BeirutB.S., 1976 - 1980
American University of Beirut Faculty of MedicineClass of 1980
Certifications & Licensure
NJ State Medical License 2003 - 2027
MD State Medical License 1986 - 2008
OH State Medical License 1984 - 1992
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2012-2017
- CMS Meaningful Use Stage 1 Certification Centricity EMR, GE Healthcare, 2012-2017
- CMS Meaningful Use Stage 2 Certification Centricity EMR, GE Healthcare, 2012-2017
Clinical Trials
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS) Start of enrollment: 2007 Mar 01
Publications & Presentations
PubMed
- Effect of diroximel fumarate on gut dysbiosis and autoimmunity in the central nervous system.Sudhir Kumar Yadav, Naoko Ito, Shradha Suresh, Yaritza Rosario, J Tamar Kalina
International Immunopharmacology. 2026-01-15 - 2 citationsThe mechanism of disease progression by aging and age-related gut dysbiosis in multiple sclerosis.Sudhir Kumar Yadav, Claire Chen, Suhayl Dhib-Jalbut, Kouichi Ito
Neurobiology of Disease. 2025-08-01 - 1 citationsAlternative Splicing in Multiple Sclerosis: A Promising Biomarker of Therapeutic Response to Interferon-β.Suhayl Dhib-Jalbut
Journal of Interferon & Cytokine Research. 2024-08-01
Journal Articles
- Current use of biomarkers to guide MS therapiesDhib-Jalbut SS, IJMSC, 10/1/2013
- From emerging agents to biomarkers: Integrating scientific advances into MS managementDhib-Jalbut SS, Markowitz CE, Miller A, IJMSC, 1/1/2013
- Immune response during Interferon-beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse free in the START studyDhib-Jalbut SS, Sumandeep S, Valenzuela RM, Ito K, Patel P, Rametta M, J Neuroimmunol, 1/1/2013
Lectures
- Minimizing Risks and Maximizing Efficacy for Management of Multiple SclerosisCMEducation Resources, LLC, San Jose, California - 4/20/2013
- Minimizing Risks and Maximizing Efficacy for Management of Multiple SclerosisCMEducation Resources, LLC, Dallas, Texas - 4/13/2013
- Minimizing Risks and Maximizing Efficacy for Management of Multiple SclerosisCMEducation Resources, LLC, Atlanta, Georgia - 4/6/2013
Press Mentions
RWJBarnabas Health Stroke Centers Recognized by American Heart Association, U.S. News & World Report Best HospitalsAugust 6th, 2025
Aug 5, 2025 RWJBarnabas Health Stroke Centers Achieve National Recognition from American Heart Association, U.S. News & World Report Best Hospitals for 2025–26August 5th, 2025
Cooperman Barnabas Medical Center Achieves Highest Level of Stroke Certification from the Joint CommissionFebruary 20th, 2025
Grant Support
- Effect of dysbiotic gut microbiota on the transport of short-chain fatty acids: Relevance to autoimmune disordersRUTGERS BIOMEDICAL AND HEALTH SCIENCES2024–2026
- Bdnf-Engineered Stem Cell Mediated Neuroprotection In EAENational Institute Of Neurological Disorders And Stroke2009–2010
- Interferon-B And Copolymer-I In Multiple Sclerosis.National Institute Of Neurological Disorders And Stroke2003
- Interferon-B And Copolymer-I In Multiple Sclerosis.National Institute Of Neurological Disorders And Stroke1999–2002
- Regulation &Function Of Class-Ii HLA Molecules In Measles Infected Human GliaNational Institute Of Neurological Disorders And Stroke1992–1996
Committees
- Member, ASENT Program Committee 2019 - Present
- Member, Data Safety Monitoring Board-NIAID 2010 - Present
Professional Memberships
- Fellow
- American Neurological Association ANAFellow
- International Society for Neuroimmunology-ISNIMember
- American Society for Experimental Neurotherapeutics-ASENTMember
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









